Need a specific person's email?
Browse Agendia's employee directory (about 224 employees) and reveal verified emails free.
Agendia's most common email format is First.Last@agendia.com (ex. John.Doe@agendia.com), used for 96% of agendia.com addresses. Agendia uses 3 email patterns.
| Format | Example | Share of agendia.com |
|---|---|---|
| First.Last@agendia.comMost common | John.Doe@agendia.com | |
| F.Last@agendia.com | J.Doe@agendia.com | |
| First.Middle@agendia.com | John.Michael@agendia.com |
Browse Agendia's employee directory (about 224 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States201-500 Employees
Agendia is an Irvine, California-based biotechnology company focused on precision oncology for early-stage breast cancer. It offers MammaPrint, a 70-gene recurrence assay, and BluePrint, an 80-gene molecular subtyping test; MP is FDA-cleared for risk of recurrence and CE-marked, while BP is CE-marked but not FDA-cleared, and both can be ordered on core biopsies or surgical specimens. The tests are supported by clinical, guideline, peer-reviewed, and real-world evidence, and analyses are conducted in a CLIA-certified laboratory. In 2026, NCCN updated its guidelines recognizing MammaPrint to guide personalized anthracycline use in HR+/HER2- early-stage breast cancer. The company operates within the biotechnology research space, aligning its genomic testing with guideline-driven, precision medicine approaches for breast cancer.
Most common format
First.Last@agendia.com
Example: John.Doe@agendia.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.